"The NuCapCure project can revolutionise cancer treatment, aiming to offer curative yet cost-effective alternatives for GBM, providing significant benefits for patients, healthcare systems, and the society as a whole." Dr Theodossis Theodossiou – Universitetet i Oslo
NuCapCure project coordinator
About us
NuCapCure's mission is to revolutionise modern oncology through two ground-breaking treatments for the world's most common and deadliest brain tumour with no curative treatment, Glioblastoma multiforme (GBM), and thus promote the well-being of global societies. The European Innovation Council (EIC) recognised the potential of the project to deliver a visionary and disruptive innovation that could result in significant societal benefit. It has therefore funded NuCapCure as part of the Pathfinder Open Programme in Horizon Europe.
